WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹66 Cr | ₹61 Cr | ₹58 Cr | ₹43 Cr | ₹38 Cr |
What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹66 Cr |
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹58 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹38 Cr |
How is Consolidated Net Profit of WINDLAS BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹66 Cr | 8.95 | |
| Mar2025 | ₹61 Cr | 4.82 | |
| Mar2024 | ₹58 Cr | 36.51 | |
| Mar2023 | ₹43 Cr | 11.91 | |
| Mar2022 | ₹38 Cr | - | |
Compare Consolidated Net Profit of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,764.7 Cr | -0.3% | -0.6% | -7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.3% |
-0.6% |
-7.8% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses